Tokuhiko in vitro diagnostic blood bank centrifuge (unsterilized)
Taiwan·Risk Class 1·Deyan Medical Technology Instrument Co., Ltd.; Deyan Medical Technology Instrument Co., Ltd. Factory 1·Registered Oct 08, 2018 – Oct 08, 2023Cancelled- Analysis ID
- 583910855f9616560e69248c2034875c
- Manufacturer
- Deyan Medical Technology Instrument Co., Ltd.; Deyan Medical Technology Instrument Co., Ltd. Factory 1
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- DIGISYSTEM LABORATORY INSTRUMENTS INC.
- Intended Use
- Limited to the first level identification range of blood bank centrifuge (B.9275) for in vitro diagnostic of medical equipment management methods.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9275 Blood bank centrifuge for in vitro diagnostics
- Import Information
- Domestic;; Contract manufacturing
- Registration Date
- Oct 08, 2018
- Expiry Date
- Oct 08, 2023
- Cancellation Date
- Sep 30, 2021
- Status
- Logged out
- Reason
- 轉為登錄字號
Top companies providing products similar to "Tokuhiko in vitro diagnostic blood bank centrifuge (unsterilized)"
Recently registered similar products
Access comprehensive regulatory information for Tokuhiko in vitro diagnostic blood bank centrifuge (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 583910855f9616560e69248c2034875c and manufactured by Deyan Medical Technology Instrument Co., Ltd.; Deyan Medical Technology Instrument Co., Ltd. Factory 1. The authorized representative in Taiwan is DIGISYSTEM LABORATORY INSTRUMENTS INC..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Deyan Medical Technology Instrument Co., Ltd.; Deyan Medical Technology Instrument Co., Ltd. Factory 1, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.